Biotech’s Historic Month (And Whether It Can Last)

After three straight months of losses, April brought the S&P 500 health care sector its best one-month gain in twenty years, and today’s article notes that “The sector’s top performing stocks were diagnostic firms at the heart of the Covid-19 testing expansion.” Moreover, the biotech sector outpaced both the health care sector and the overall market, again with Covid-related biotech stocks being among the best performers. For more on biotech’s recent performance – and whether it can last – CLICK HERE.